The 2 analysts offering 12-month price forecasts for Guardion Health Sciences Inc have a median target of 0.70, with a high estimate of 0.80 and a low estimate of 0.60. The median estimate represents a +406.88% increase from the last price of 0.14.
The current consensus among 2 polled investment analysts is to Buy stock in Guardion Health Sciences Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.03
Reporting Date Nov 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.